© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#ASH 2018
Click Here for More Conferences
Click Here for ASH Online
Blood Cancers 101
The U.N. General Assembly Hall during the High-level Meeting on HIV/AIDS.

Conferences

Targeted Treatment for Leukemia

Imbruvica plus Gazyva is the first chemotherapy-free regimen for chronic lymphocytic leukemia.
Red and white blood cells

FDA Approves Targeted Therapy Combo for Leukemia

Imbruvica plus Gazyva is the first chemotherapy-free regimen for chronic lymphocytic leukemia.
Red and white blood cells

Venclexta Provides Sustained Benefit for People With Leukemia

Venclexta alone or in combination with Rituxan improved progression-free survival in patients with chronic lymphocytic leukemia.
A patient’s T cells arrive at the Novartis manufacturing facility in Morris Plains, where they will be re-engineered to recognize and fight cancer and healthy cells expressing a specific antigen in the patient’s body.

CAR-T Therapy Leads to Durable Response

Long-term remission seen in children with leukemia and adults with lymphoma.
Damian Green, MD, presented the first results from his trial of genetically engineered immune cells for multiple myeloma. Green says this type of treatment could “dramatically alter the landscape in terms of how we manage multiple myeloma.”

‘Exciting’ but Early Results in Trial of Immunotherapy for Myeloma

Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease.
Jennifer Woyach, MD

Imbruvica Bests Chemotherapy for Older People With Leukemia

Imbruvica-based treatment may also work better than intensive chemotherapy for younger patients.
Red and white blood cells

CAR-T Therapy Shows Promise for Chronic Lymphocytic Leukemia

Customized cell therapy plus Imbruvica leads to high response rate.

Studies Offer Glimpses into the Future of Medicine for Blood Cancers

ASH 2018 conference highlights precision medicine, machine learning and gut microbiome.
Advertisement
Treatment News
Newsfeed